Newly on Gate2Biotech
Fertile discovery
28.8.2014 | Newly on Gate2Biotech
Queen’s University researcher Richard Oko and his co-investigators have come up with a promising method of treating male infertility using a synthetic version of the sperm-originated protein known as PAWP. They found this protein is sufficient and required to initiate the fertilization process. Dr. Oko’s research promises to diagnose and treat...
Testosterone in Healthy Men Increases Their Brains’ Response to Threat
26.8.2014 | Newly on Gate2Biotech
Philadelphia, PA, August 11, 2014 Testosterone, a steroid hormone, is well known to contribute to aggressive behavior in males, but the neural circuits through which testosterone exerts these effects have not been clear. Prior studies found that the administration of a single dose of testosterone influenced brain circuit function. Surprisingly,...
How the woodpecker avoids brain injury despite high-speed impacts via optimal anti-shock body structure
22.8.2014 | Newly on Gate2Biotech
Designing structures and devices that protect the body from shock and vibrations during high-velocity impacts is a universal challenge. Scientists and engineers focusing on this challenge might make advances by studying the unique morphology of the woodpecker, whose body functions as an excellent anti-shock structure. The woodpecker's brain...
Nanocubes Get in a Twist
20.8.2014 | Newly on Gate2Biotech
Nanocubes are anything but child’s play. Weizmann Institute scientists have used them to create surprisingly yarn-like strands: They showed that given the right conditions, cube-shaped nanoparticles are able to align into winding helical structures. Their results, which reveal how nanomaterials can self-assemble into unexpectedly beautiful and...
Sensitive acid sensor controls insulin production
18.8.2014 | Newly on Gate2Biotech
ETH Zurich researchers from the Department of Biosystems Science and Engineering (D-BSSE) in Basel have developed an implantable device that precisely monitors acid build-up in the body for people with diabetes and produces insulin if acidosis becomes a risk.
Outbreak of Ebola virus disease in West Africa
14.8.2014 | Newly on Gate2Biotech
On 8 August, the World Health Organisation declared the outbreak of Ebola virus disease (EVD) evolving in West Africa a Public Health Emergency of International Concern (PHEIC).
CTO of the Year Europe award launched – who is the most innovative technology leader in Europe?
11.8.2014 | Newly on Gate2Biotech
The open call for nominations for Europe’s most prominent technology leader was launched in June 2014 in Copenhagen by Spinverse and EIRMA, the European Industrial Research Management Association. The Award will be given to the most inspiring, innovative and foresighted technology leader in Europe; awarded in October in the Nethe...
Infectious disease - new rapid assay detects cytomegalovirus
17.7.2014 | Newly on Gate2Biotech
New Iam CMV provides speed and accuracy for the diagnosis and monitoring of CMV infection in immunocompromised patients. DiaSorin strengthens its infectious disease diagnostic portfolio with the launch of the Iam CMV assay for the molecular detection and quantification of cytomegalovirus.
New Iam HSV provides rapid molecular confirmation of HSV infection in immunocompromised individuals and in cases of herpes simplex encephalitis
10.7.2014 | Newly on Gate2Biotech
DiaSorin has further strengthened its range of infectious disease diagnostic assays for use on the DiaSorin Liaison® Iam analyser with the launch of Iam HSV. This new molecular assay provides rapid and reliable differential detection of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in human cerebrospinal fluid (CSF), vesicle swabs, plasma...
From Genes to Therapy
12.5.2014 | Newly on Gate2Biotech
See DiaSorin automated cell separation and nucleic acid extraction products at EFI 2014, Stockholm, Sweden – Stand S5
